Want to see NL:AVTX full AI Analyst Report?
Top Page
Avantium N.V.
(AVTX)
Select Model
Select Model
Rating:41Neutral
Price Target:
€2.50
▼(-48.77% Downside)
Action:Reiterated
Date:10/29/26
The score is held down primarily by weak financial performance—persistent losses, negative gross profit, and ongoing cash burn—despite some balance sheet equity improvement. Technicals also remain very bearish with the stock below all major moving averages and extremely weak momentum. Valuation provides limited support because the company is loss-making (negative P/E) and no dividend yield is available.
Positive Factors
Proprietary sustainable materials platform
Avantium has a defined technology platform targeting renewable and circular polymers, including PEF and chemical building blocks. This creates several routes to commercialization through licensing, partnerships, services, and products, supporting longer-term strategic relevance if adoption develops.
Negative Factors
Declining revenue
The 2025 revenue decline shows that Avantium has not yet established a consistently expanding commercial base. Uneven top-line performance can delay operating leverage, weaken confidence in near-term scale-up economics, and make future funding and commercialization milestones more difficult to achieve.
Read all positive and negative factors
Positive Factors
Negative Factors
Proprietary sustainable materials platform
Avantium has a defined technology platform targeting renewable and circular polymers, including PEF and chemical building blocks. This creates several routes to commercialization through licensing, partnerships, services, and products, supporting longer-term strategic relevance if adoption develops.
Read all positive factors
Avantium N.V. (AVTX) vs. iShares MSCI Netherlands ETF (EWN)
Market Cap
€163.21M
Dividend YieldN/A
Average Volume (3M)142.08K
Price to Earnings (P/E)―
Beta (1Y)1.53
Revenue Growth-32.85%
EPS Growth26.72%
CountryNL
Employees245
SectorGeneral
Sector StrengthN/A
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)-1.50
Shares Outstanding25,206,718
10 Day Avg. Volume169,340
30 Day Avg. Volume142,082
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)0.60
Price to Sales (P/S)6.22
P/FCF Ratio-1.55
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€12.50Price Target Upside156.15% Upside
Rating ConsensusHold
Number of Analyst Covering2
EPS Forecast (FY)-1.29
Revenue Forecast (FY)€31.05M
Avantium N.V. Business Overview & Revenue Model
Company Description
Avantium N.V., an Amsterdam-based chemical technology enterprise, specializes in the development and commercialization of sustainable chemistry innovations. Its operations are structured across three distinct segments: Avantium Catalysis, Avantium...
How the Company Makes Money
Avantium makes money primarily by commercializing proprietary chemical process technologies and materials through a mix of (1) technology licensing, (2) R&D/services income, and (3) product sales where applicable.
1) Technology licensing and rela...
Avantium N.V. Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
46
Neutral
Cash Flow
22
Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 12.60M | 14.59M | 21.04M | 19.70M | 17.83M | 10.92M |
| Gross Profit | -45.47M | -34.38M | -30.57M | -25.30M | -24.55M | -25.37M |
| EBITDA | -39.03M | -39.47M | -24.52M | -25.78M | -19.59M | -16.09M |
| Net Income | -35.28M | -22.52M | -26.87M | -31.40M | -28.13M | -24.42M |
Balance Sheet | ||||||
| Total Assets | 332.86M | 356.17M | 288.63M | 228.49M | 163.58M | 77.67M |
| Cash, Cash Equivalents and Short-Term Investments | 23.87M | 57.47M | 23.90M | 35.22M | 64.87M | 34.91M |
| Total Debt | 171.56M | 165.06M | 151.59M | 108.82M | 24.59M | 10.70M |
| Total Liabilities | 211.69M | 206.57M | 190.84M | 174.62M | 70.56M | 27.65M |
| Stockholders Equity | 129.34M | 152.52M | 95.85M | 46.17M | 82.58M | 50.03M |
Cash Flow | ||||||
| Free Cash Flow | -64.33M | -58.54M | -103.39M | -108.14M | -45.12M | -16.54M |
| Operating Cash Flow | -41.21M | -37.89M | -45.06M | -18.82M | -11.17M | -12.61M |
| Investing Cash Flow | -22.43M | -20.66M | -58.63M | -89.77M | -33.95M | -3.93M |
| Financing Cash Flow | 75.46M | 92.11M | 83.36M | 78.94M | 75.08M | 24.83M |
Avantium N.V. Technical Analysis
Negative
4.88
Price Trends
3.27
Negative
4.03
Negative
4.45
Negative
Market Momentum
-0.16
Positive
30.78
Neutral
15.38
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NL:AVTX, the sentiment is Negative. The current price of 4.88 is above the 20-day moving average (MA) of 3.15, above the 50-day MA of 3.27, and above the 200-day MA of 4.45, indicating a bearish trend. The MACD of -0.16 indicates Positive momentum. The RSI at 30.78 is Neutral, neither overbought nor oversold. The STOCH value of 15.38 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for NL:AVTX.
Avantium N.V. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | €25.33B | -21.94 | ― | 2.36% | -44.75% | -301.20% | |
66 Neutral | €10.19B | 15.60 | 13.55% | 3.33% | -5.00% | 1020.46% | |
63 Neutral | €1.49B | 23.98 | 8.30% | 2.35% | -3.37% | -8.22% | |
62 Neutral | €5.93B | 25.78 | 11.06% | 1.80% | 2.64% | -14.83% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
52 Neutral | €866.37M | -73.11 | -13.87% | 17276.13% | ― | ― | |
41 Neutral | €163.21M | -1.85 | -25.04% | ― | -32.85% | 26.72% |
* General Sector Average
NL:AVTX
Avantium N.V.
2.78
-1.49
-34.90%
NL:AKZA
Akzo Nobel NV
59.42
3.21
5.72%
NL:CRBN
Corbion NV
25.90
9.19
55.02%
NL:IMCD
IMCD N.V.
100.55
11.92
13.45%
NL:OCI
OCI N.V.
4.11
0.67
19.62%
NL:DSFIR
DSM-Firmenich AG
105.75
36.48
52.67%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.